用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Breast Cancer Metastasis and Drug Resistance; Progress and Prospec Aamir Ahmad Book 20131st edition Springer Science+Business Media New Yor

[复制链接]
楼主: 日月等
发表于 2025-3-26 22:11:55 | 显示全部楼层
发表于 2025-3-27 01:26:40 | 显示全部楼层
Development of Notch Pathway Inhibitors for Cancer Therapy,ing developed. In this review, we describe the basics of Notch signaling, the role of Notch in normal and cancer stem cells; finally we describe opportunity and challenges in the development of Notch inhibitors as novel targeted agents for cancer patients.
发表于 2025-3-27 09:16:57 | 显示全部楼层
Epigenetic Factors in Breast Cancer Progression,processes involved in the initiation and progression of breast carcinogenesis. This chapter describes the major epigenetic modifications involved in breast carcinogenesis and use of various epigenetic modulators in preclinical as well as in clinical trials against breast carcinogenesis.
发表于 2025-3-27 12:17:09 | 显示全部楼层
Understanding Tamoxifen Resistance of Breast Cancer Based on Integrative Bioinformatics Approaches,The analyses reveal that the tamoxifen resistant tumors are highly proliferative and display a distinctive expression profile for genes related to inflammation and angiogenesis compared to tamoxifen sensitive tumors. The bioinformatics analysis also identifies a set of small molecules that may reverse the tamoxifen resistance in breast tumor.
发表于 2025-3-27 15:14:59 | 显示全部楼层
Utility, Limitations and Lacunae platinum and ruthenium based drugs against breast cancer. Chemical formulae and a brief description of the manifold biological activities of some important such compounds are provided which might be of interest to inorganic chemists, medicinal chemists, biologists, and clinicians alike.
发表于 2025-3-27 21:49:23 | 显示全部楼层
Gabriele Gaziev,Enrico Finazzi Agròancer. Furthermore, these molecular signatures could not only help to identify new therapeutic targets, but also allow physicians to design more effective and targeted therapeutic strategies for achieving better treatment outcomes of breast cancer patients.
发表于 2025-3-27 23:04:03 | 显示全部楼层
发表于 2025-3-28 04:57:03 | 显示全部楼层
发表于 2025-3-28 08:03:01 | 显示全部楼层
发表于 2025-3-28 10:27:49 | 显示全部楼层
s and some novel signaling pathways?.Excellent source for of​This volume comprehensively covers recent prrogress in breast cancer research. In an effort to successfully treat breast cancer, it is imperative to a) fully understand the disease with all its heterogeneity, b) understand the factors that
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-1 17:03
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表